Overview

For procurement teams, avatrombopag's story is less about novelty and more about documentation: GMP certification, batch release testing, and import compliance decide whether a shipment clears customs and reaches patients. AVALET provides avatrombopag 20 mg tablets in 28-tablet boxes for thrombocytopenia in chronic liver disease. This article outlines the quality and regulatory checkpoints B2B buyers must verify before purchase. Treating the certificate of analysis as a non-negotiable deliverable protects both the supply chain and the end patient.

How It Works

Avatrombopag is an oral thrombopoietin receptor agonist that activates TPO-R on megakaryocytes, increasing platelet production in patients whose counts are suppressed by chronic liver disease. Unlike infused options, the tablet form simplifies outpatient management. From a compliance standpoint, the identical active ingredient must be manufactured under validated processes, because inconsistent bioavailability would undermine the predictable platelet rise that procedures depend on. Quality systems therefore sit at the centre of its reliable use.

Indications

Avatrombopag is indicated to treat thrombocytopenia in adults with chronic liver disease scheduled for a procedure, and for chronic immune thrombocytopenia per local labelling. The 28-tablet pack supports the short, defined courses used before planned interventions. Regulatory buyers should match order volumes to confirmed procedure schedules, since the medicine is prescription-only and used within a narrow clinical window.

Dosage & Administration

For procedure-related thrombocytopenia in liver disease, avatrombopag is taken as 20 mg (one tablet) once daily for five days, with the procedure performed 5 to 8 days after the last dose. Tablets are swallowed whole with food. A 28-tablet box covers the course with margin. Dose selection follows labelling and liver-function parameters; no routine splitting is applied.

Storage & Sourcing

Store below 30°C in the original packaging, away from moisture and light. Because avatrombopag is a prescription product, B2B orders require the supplier's manufacturing licence, GMP certificate, and a batch-specific certificate of analysis stating identity, assay, and impurity limits. Confirm remaining shelf life at dispatch and the product registration for your market. Reputable sourcing records every batch number to enable traceability if a quality query arises.

FAQ

Q: What quality documents must accompany an avatrombopag shipment? A: Expect a GMP certificate, a batch-specific certificate of analysis covering assay and impurities, and proof of market authorisation for the destination.

Q: How should buyers verify batch traceability? A: Record the batch number and expiry on receipt and keep them linked to the supplier invoice so any quality issue can be traced to a single lot.

Q: Does avatrombopag need cold-chain transport? A: No. Room-temperature storage below 30°C is specified, though temperature-protected transit is sensible in hot climates.